The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Apologies for posting again but feel in need of a sense of perspective. I spent 16 years advising companies on innovation and helping companies scale-up. For me innovation is the commercialisation of ideas and the journey is a circle. Start with an idea, protect it with patents, trade marks, design registration (and/or secrecy agreements for know-how) as you will. Then research (including market research) and develop before moving into manufacture. That is all money out the door, yours or someone else's. Sales into the market is next, often domestic to begin before going international. That completes the cycle so you then go round again, this time with cappuccino rather than coffee perhaps, and try and do it fast. That is exactly what Novacyt are doing, both properly and quickly. Sadly Covid is with us for a long time yet, but don’t think of Novacyt being a one trick pony; they have over 500 other tests and with their agile team can develop other tests. Heavyweights are joining the company and if you doubt the CEO's capabilities visit his profile at https://www.linkedin.com/in/graham-mullis. The share price is a roller coaster so buy in or sell if you can’t wait things out. They have ample funds to acquire or develop new products and markets and can weather setbacks. The DHSC problem will get resolved. I am very heavily invested and plan on holding for a very long time as they continue to scale up. Ignore the shorters if you can, do your own research but have some perspective.
Of those 394 trades, 39 were for Algo trades for 830 shares all around the same total value of £2,724 up to £2,793. In total there were 120 Algo trades which in a perverse sort of way I take it as reassuring that the price is artificially driven low. I am hanging on to my shares for the long haul. Not trading and not selling.
Long term holders such as myself and others may be interested in this webinar held yesterday - see https://www.searchinglifescience.com/media/1181/live-webinar-whats-next-for-lateral-flow
An interesting discussion with participants from Abingdon Health, Katalyst Labs and Drummond Scientific - respectively a rapid test developer and manufacturer, a distributor of various tests inc PCR and an equipment manufacturer. Katalyst know us of course. I wonder who we have partnered with on the LFT front?
Hi BB, Well I am with you and bought again this morning with last bit of spare cash. Just have a feeling that we might see an RNS on Friday before the bank holiday. If anyone is in any doubt about the CEO's capabilities take a look at his profile at https://www.linkedin.com/in/graham-mullis/
Hi Naewise, I think we all appreciate some of your points. Regarding the DHSC contract that was announced on the 29th September; the week before the share price was closing between 396 and 467, so in round figures not a lot different from now. The question I would ask is how is Novacyt placed now by comparison? In October they bought IT-IS and have gone on to develop their battery of weapons. They have a pile of money in the bank (don't know exactly but a lot!) and a larger and stronger team. Who knows what the future holds but sadly I think Covid will be around for a long time leading to on-going demand around the world. They now have a battery of different Covid tests and a strengthened team. Eventually the company will be able to switch to developing tests for different things. Just seems to me right now the share price is simply not reflecting the facts or the potential of this innovative company.
Cheers Van. At 6ft I just fit in the MG! I just think we need to stand back a bit and look at the progress and try to get into understanding the thinking of GM and his team. Battling Covid is just the catalyst; I wish it was an easier battle and I don't think the battle with Covid will be over by Christmas. So stay safe everyone.
For those interested in Novacyt you may welcome this perspective. I spent the last 16 years advising companies on innovation and helping companies scale-up. For me innovation is the commercialisation of ideas and the journey is a circle. Start with an idea, protect it with patents, trade marks, design registration and/or secrecy agreements for know-how as you will. Then research (including market research) and develop before moving into manufacture. All those activities are money out the door, yours or someone else's. Sales into the market is next, often domestic to begin before going international. That completes the cycle so you then go round again, this time with cappuccino rather than coffee perhaps, and try and do it fast. That is exactly what Novacyt are doing, both properly and quickly. I don't see them standing still if demand for Covid tests stopped, but move to other areas of growth with the agile team they have grown. It may be a roller coaster share price wise, but to me they are just concentrating on building the business. The funds available mean they can acquire or develop new products and markets as well as weather any setbacks. I am very heavily invested and plan on holding for a very long time as they continue to scale up. Ignore the shorter if you can, do your own research but have some perspective.
I spent the last 16 years advising companies on innovation and helping companies scale-up. For me innovation is the commercialisation of ideas and the journey is a circle. Start with an idea, protect it with patents, trade marks, design registration and/or secrecy agreements for know-how as you will. Then research (including market research) and develop before moving into manufacture. All those activities are money out the door, yours or someone else's. Sales into the market is next, often domestic to begin before going international. That completes the cycle so you then go round again, this time with cappuccino rather than coffee perhaps, and try and do it fast. For me Novacyt are doing exactly that, so they may not be sharing their plans hence frustration but they seem to know how to go round the innovation journey fast and that is what gave me the confidence to invest a bundle. Clearly there can be lots of challenges along the way but the cash they have will help resilience as well as the costs of developing new products. I hope I am right in having some faith but just do you own research. Stay safe and well.
Hi Soder, It was just too low to resist. I was lucky to get 2666 shares at 375.0451 in one go this morning; almost £10k - someone can check it out as it should show as buy. That was the last cash I had in my SIPP which is now 86% in Novacyt. My ISA is 100% in Novacyt. It would hurt if I sold but not going to anytime soon. This roller coaster is not over by any means. Looking forward to all the great developments being monitized in the markets at home and abroad.
I found myself writing to my MP yesterday about putting India on the red list. Crazy not to; however good we might be (or not) at picking up things once they are in the community. The scary thing for me is that we don't seem to be learning; one can always relax things for India or anywhere else once the facts are fully understood.